A light reception will open around 6 PM followed by discussion starting at 6:30 PM

Panel:

Andrew Leuchter, M.D. Jennifer Kruse, M.D.

David Krantz is one of the treating TMS physicians at the UCLA Transcranial Magnetic Stimulation (TMS) Clinic. He is also an attending physician at the Mood Disorders Clinic at UCLA where he has worked for the past 13 years. His primary clinical interest is depression.

Tamkin Auditorium, Ronald Reagan UCLA Medical Center757 Westwood Plaza, Room B-130Los Angeles, CA 90095Please register at https://advances-in-the-treatment-of-depression-tickets.eventbrite.com

Andrew Leuchter is the Director of the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service and the Neuromodulation Division at UCLA. He is an expert in the use of TMS for the treatment of Major Depressive Disorder (MDD), and its potential uses for other neuropsychiatric disorders, including anxiety and PTSD.

Recent clinical advances offer new hope for patients suffering from depression. Join us for a special one-hour presentation by experts in depression who will discuss Transcranial Magnetic Stimulation (TMS), ketamine, and the latest research advances that can help patients recover from treatment-resistant depression.

Presenters will include:Andrew Leuchter, M.D., Professor and Director of the TMS Clinical and Research ServiceJennifer Kruse, M.D., Assistant Professor and Director of the Consultation-Liason Psychiatry Fellowship David Krantz, M.D., Ph.D., Professor and lead investigator on the sTMS Research Study

Jennifer Kruse is a consultation-liaison psychiatrist with expertise in mood disorders, the psychiatric care of medically ill patients, and pharmacology. She directs the Consultation-Liaison Psychiatry Fellowship at UCLA and supervises trainees on the Psychiatry Consultation Service at Ronald Reagan Medical Center, in the Mood Disorders Clinic at UCLA, and in the Primary Care-Mental Health Integration Clinic at the West Los Angeles VA.

David Krantz, M.D., Ph.D.